Betaliq Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Reverse Merger
  • (Upcoming)

  • Investors
  • 5

Betaliq General Information

Description

Operator of a biotechnology company intended to develop ophthalmic drugs to treat glaucoma. The company's platform leverages a water-free drug delivery technology to optimize treatment outcomes, featuring extended residual time, minimized systemic exposure, a preservative-free composition, and ocular surface benefits, enabling doctors to address unmet glaucoma and hereditary angioedema needs.

Contact Information

Website
www.betaliq.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 905 East Martin Luther King Jr. Drive
  • Suite 240
  • Tarpon Springs, FL 34689
  • United States
+1 (813)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 905 East Martin Luther King Jr. Drive
  • Suite 240
  • Tarpon Springs, FL 34689
  • United States
+1 (813)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Betaliq Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Reverse Merger Upcoming Clinical Trials - Phase 3
3. Mezzanine 02-Jun-2025 Completed Clinical Trials - Phase 3
2. Early Stage VC (Series A) 26-Jul-2019 $6M $6M Completed Clinical Trials - Phase 2
1. Joint Venture 10-Oct-2018 Completed Clinical Trials - Phase 2
To view Betaliq’s complete valuation and funding history, request access »

Betaliq Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Betaliq’s complete cap table history, request access »

Betaliq Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Collage Venture Partners Venture Capital Minority
Evolution VC Partners Venture Capital Minority
Green Park & Golf Ventures Venture Capital Minority
BLP Management Group Corporation Majority
Novaliq VC-Backed Company Majority
To view Betaliq’s complete investors history, request access »

Betaliq FAQs

  • When was Betaliq founded?

    Betaliq was founded in 2018.

  • Where is Betaliq headquartered?

    Betaliq is headquartered in Tarpon Springs, FL.

  • What industry is Betaliq in?

    Betaliq’s primary industry is Drug Discovery.

  • Is Betaliq a private or public company?

    Betaliq is a Private company.

  • What is Betaliq’s current revenue?

    The current revenue for Betaliq is .

  • How much funding has Betaliq raised over time?

    Betaliq has raised $6.42M.

  • Who are Betaliq’s investors?

    Collage Venture Partners, Evolution VC Partners, Green Park & Golf Ventures, BLP Management Group, and Novaliq have invested in Betaliq.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process